Andrawis Zada, OD
Optometry · San Mateo, CANPI 1174265169
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by Alcon at 48.9% of the total. Reporting peaked in 2024 at $2,291 and has fallen 55.5% since, to $1,019 in 2025. Among optometry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $146.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Coopervision Inc.$854
- Biotissue Holdings Inc.$216
- Tarsus Pharmaceuticals, Inc.$160
- AbbVie$126
- Bausch & Lomb Americas Inc.$125
- plus $395 from 4 others
What the payments were for
- Travel & lodging$2,03755%
- Food & beverage$1,63445%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 9 | $1,795 |
| Coopervision Inc. | 4 | $854 |
| Biotissue Holdings Inc. | 2 | $216 |
| Tarsus Pharmaceuticals, Inc. | 4 | $160 |
| AbbVie | 1 | $126 |
| Bausch & Lomb Americas Inc. | 1 | $125 |
| Sun Pharmaceutical Industries Inc. | 1 | $118 |
| Oyster Point Pharma, Inc. | 1 | $98 |
| Apellis Pharmaceuticals, Inc. | 1 | $93 |
| Rxsight Inc | 1 | $87 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clariti Contact Lens$620
- MyDay Contact Lens$215
- TOTAL30$133
- DURYSTA$126
- VYZULTA$125
- CEQUA$118
How this compares
$3,671 in reported general payments places this provider in the 95th percentile of 99 optometry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 13 | $4,434 |
Paid to pharmacies, not to this prescriber.
Other optometry in San Mateo
- Sarah KwokSanta Clara$1K
- Justin OgoyRedlands$1K
- Edgar AguilarEl Centro$550
- Mark ParkDelano$0
- Kevin TalagaSacramento$0
- Alexis WinnCupertino$0
- Victor AraiPasadena$0
- Vida ArjomandSanta Ana$0
- Dessie AthensPalo Alto$0
- Doro HsuBerkeley$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.